Skip to main content

Tamar Securities, LLC

Broker-Dealer

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1703081 Woodland Hills, CA

Position in REGN

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$27,196,155
-$4,030,617 QoQ
Shares Held
35,199
-13.0% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
3.76%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Mar 31, 2026
CallValue
$77,264
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Tamar Securities, LLC holds $27,323,485 across 3 Biotechnology names. REGN ranks #1 (99.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
35,199 $27,196,155

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $77,264 100
2026-03-31 $27,196,155 35,199
2025-12-31 $31,226,772 40,456
2025-09-30 $18,142,203 32,266
2025-06-30 $15,950,025 30,381
2025-03-31 $17,843,426 28,134
2024-12-31 $14,532,244 20,401
2024-09-30 $16,285,810 15,492
2024-06-30 $13,958,729 13,281
2024-03-31 $13,486,409 14,012
2023-12-31 $12,496,310 14,228
2023-09-30 $10,594,787 12,874
2023-06-30 $9,369,761 13,040
2023-03-31 $9,424,554 11,470
2022-12-31 $9,126,848 12,650
2022-09-30 $8,794,114 12,766
2022-06-30 $7,259,076 12,280
2022-03-31 $8,353,801 11,961
2021-12-31 $6,696,006 10,603
2021-09-30 $6,508,710 10,755
2021-06-30 $6,049,546 10,831
2021-03-31 $4,798,585 10,142
2020-12-31 $3,979,860 8,238
2020-09-30 $4,238,094 7,571
2020-06-30 $4,427,291 7,099